Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Geron Corp. Grants License to P&G - Happi
Company News

Geron Corp. Grants License to P&G

Biopharmaceutical company Geron Corp. has granted a non-exclusive license to Procter & Gamble relating to Geron’s human telomerase reverse transcriptase (hTERT) technology for cell research applications. Financial terms of the agreement were not disclosed.
P&G plans to use the technology to create immortalized cell lines from certain types of skin cells to study the regulation of cell function and to develop biological tests for screening purposes.
Cell lines immortalized with hTERT technology can proliferate indefinitely while maintaining normal physical and biological characteristics, according to experts. Executives said this means P&G will be able to conduct repeated or long-term studies on the biology and functin of the cells.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters